ArticleJournal for immunotherapy of cancer2022

Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.